Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Columbia Care Inc.
  6. News
  7. Summary
    CCHW   CA1973091079

COLUMBIA CARE INC.

(CCHW)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

New York's pot legalization adds urgency to U.S. reform calls

03/31/2021 | 03:00pm EDT

March 31 (Reuters) - New York's legalization of recreational marijuana could generate $5 billion in sales for the first year and raises pressure on other states to follow the 16 that have now approved the plant for everyday use, the head of one of the country's biggest producers said on Wednesday.

New York Governor Andrew Cuomo on Wednesday signed a bill paving the way for recreational sales of marijuana to begin in the state next year, pushing an ETF tracking U.S. pot producers' stocks up more than 6% and on track for its best day since the U.S. presidential election.

Ben Kovler, chief executive officer of Green Thumb Industries Inc, the second largest U.S. pot producer by market value, said his company will allocate "significant dollars" to the New York market - set to be the second largest legal market after California.

New York could be worth more than $5 billion in just its first year of sales, without including "cannabis tourism" from other states, Kovler said in an interview.

"New York is New York, (there) couldn't be a bigger deal," Kovler said.

Global X Research analyst Pedro Palandrani estimated that based on Cuomo's forecast of $350 million in cannabis tax revenue, the state's first year sales should top $2.5 billion to $2.7 billion.

In comparison, Colorado crossed $2 billion in total cannabis sales last year after more than five years as a recreational market, according to the state's revenue department's figures.

While the COVID-19 pandemic and resulting lockdowns cut into tax dollars that states earned from sectors like hotels and airlines, the idea of legal cannabis sales offered some hope to plug up battered fiscal budgets across the country.

"What cannabis brings and is now proven is tax revenue of a material nature," Kovler said, citing the example of Illinois, which in February collected more tax revenue from cannabis than alcohol.

Five states had legalized recreational marijuana by ballot initiatives during the November presidential election, and New York's move now puts pressure on others like Connecticut, Palandrani said.

Joseph Bayern, CEO of Curaleaf Holdings Inc, the largest U.S. cannabis company by market value, called New York's legalization a "significant milestone for the cannabis industry" and said he now expects Pennsylvania, Connecticut and Maryland would likely follow suit.

"(New York is) a quintessential emerging market, which is huge ... It will have an impact on the way the federal government thinks about legalization," said Nicholas Vita, the CEO of New York-based Columbia Care Inc.

The effects of New York's legalization will not just be limited to other governors and states, as the financial capital of the world, it also sets "a really good precedent from a federal point of view too," said Charles Bachtell, CEO of Cresco Labs Inc.

(Reporting by Shariq Khan in Bengaluru; Editing by Bernard Orr and Vinay Dwivedi)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
COLUMBIA CARE INC. 0.00% 6.77 Delayed Quote.-12.42%
CRESCO LABS INC. -0.71% 13.96 Delayed Quote.11.24%
CURALEAF HOLDINGS, INC. -0.56% 17.68 Delayed Quote.16.01%
GREEN THUMB INDUSTRIES INC. 2.82% 36.79 Delayed Quote.17.99%
All news about COLUMBIA CARE INC.
06/11Columbia Care Up after Reporting Completion of Green Leaf Medical Purchase
MT
06/11COLUMBIA CAREá : Completes Acquisition of Green Leaf Medical; Cements Market Lea..
BU
06/09COLUMBIA CAREá : Leading MSO Columbia Care Revolutionizes Customer Shopping Expe..
BU
06/07COLUMBIA CAREá : Appoints Julie Hill to its Board of Directors
BU
05/17COLUMBIA CAREá : Reports Record First Quarter 2021 Results; Reaffirms 2021 Guida..
BU
05/12COLUMBIA CAREá : Unveils National Retail Experience with Launch of Cannabist; Cr..
BU
04/28COLUMBIA CAREá : Brings Scale to New York Cannabis Program Through Acquisition o..
BU
04/23COLUMBIA CAREá : to Report First Quarter 2021 Results on Monday, May 17, 2021
BU
04/21COLUMBIA CAREá : Recognized as 11th Fastest Growing Company on the Growjo 500 - ..
BU
04/15COLUMBIA CAREá : Launches First of Its Kind Medical Cannabis Capsule in UK; Prov..
BU
More news
Financials (USD)
Sales 2021 512 M - -
Net income 2021 -14,3 M - -
Net Debt 2021 69,9 M - -
P/E ratio 2021 -167x
Yield 2021 -
Capitalization 1 751 M 1 751 M -
EV / Sales 2021 3,56x
EV / Sales 2022 2,29x
Nbr of Employees -
Free-Float 72,7%
Chart COLUMBIA CARE INC.
Duration : Period :
Columbia Care Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Average target price 11,48 $
Last Close Price 5,57 $
Spread / Highest target 183%
Spread / Average Target 106%
Spread / Lowest Target 33,9%
EPS Revisions
Managers and Directors
NameTitle
Nicholas Keane Vita Vice Chairman & Chief Executive Officer
Lars Robert Boesgaard Chief Financial Officer
Michael Abbott Executive Chairman
Rosemary Mazanet Chief Scientific Officer
David James Hart Chief Operating Officer
Sector and Competitors
1st jan.Capitalization (M$)
COLUMBIA CARE INC.-12.42%1 763
AYR WELLNESS INC.15.31%1 688
CANSORTIUM INC.43.42%286
RUBICON ORGANICS INC.-28.45%118
CANN GROUP LIMITED-30.51%88
LOWELL FARMS INC.2.76%87